TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 156 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,168,779 | -41.3% | 690,020 | +0.9% | 0.00% | -50.0% |
Q2 2023 | $10,508,283 | -32.4% | 684,133 | -1.0% | 0.00% | -33.3% |
Q1 2023 | $15,538,363 | +16.0% | 690,901 | +8.5% | 0.00% | 0.0% |
Q4 2022 | $13,390,326 | -14.0% | 636,725 | +0.7% | 0.00% | -25.0% |
Q3 2022 | $15,576,000 | +1.0% | 632,145 | -0.7% | 0.00% | +33.3% |
Q2 2022 | $15,422,000 | -4.4% | 636,514 | +1.6% | 0.00% | 0.0% |
Q1 2022 | $16,139,000 | -6.5% | 626,260 | +12.7% | 0.00% | 0.0% |
Q4 2021 | $17,252,000 | +26.9% | 555,796 | -0.9% | 0.00% | +50.0% |
Q3 2021 | $13,595,000 | +50.6% | 560,615 | -9.4% | 0.00% | 0.0% |
Q2 2021 | $9,028,000 | -43.6% | 618,745 | -3.5% | 0.00% | -33.3% |
Q1 2021 | $16,004,000 | -4.5% | 640,921 | +4.2% | 0.00% | 0.0% |
Q4 2020 | $16,758,000 | – | 614,897 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |